The relationship between serum lumican levels and myocardial fibrosis in patients with hypertrophic cardiomyopathy

Back

ESC Premium Access

The relationship between serum lumican levels and myocardial fibrosis in patients with hypertrophic cardiomyopathy

Session: Hypertrophic cardiomyopathy: risk prediction and outcomes

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor E. Hancioglu (Hatay, TR)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Emirhan Hancioglu

Samandag State Hospital, Hatay (Türkiye)

0 follower

6 more presentations in this session

CMR phenotypes and clinical outcomes in NYHA class I versus II-IV hypertrophic cardiomyopathy: identifying high-risk asymptomatic patients

Speaker: Doctor D. Labib (Calgary, CA)

High-intensity exercise-related sudden cardiac death in hypertrophy cardiomyopathy

Speaker: Doctor H. Lee (Seoul, KR)

One-year outcomes of patients with hypertrophic cardiomyopathy according to levels of inflammatory biomarkers

Speaker: Doctor M. Golino (Richmond, US)

Invasive quantitative assessment of coronary microvascular dysfunction in patients with hypertrophic cardiomyopathy

Speaker: Doctor M. Marques Antunes (Lisboa, PT)

Prolonged ventricular activation time as a novel biomarker identifying burn-out phase of hypertrophic cardiomyopathy

Speaker: Doctor K. Fragkiadakis (Heraklion, GR)

Access the full session

Hypertrophic cardiomyopathy: risk prediction and outcomes

Speakers: Doctor E. Hancioglu, Doctor D. Labib, Doctor H. Lee, Doctor M. Golino, Doctor M. Marques Antunes...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources